Biotin-PEG2-C2-iodoacetamide
CAS No. 292843-75-5
Biotin-PEG2-C2-iodoacetamide ( Biotin-PEG2-C2-iodoacetamide; Biotin-PEG2-iodoacetamide )
产品货号. M26903 CAS No. 292843-75-5
Biotin-PEG2-C2-iodoacetamide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥308 | 有现货 |
|
10MG | ¥437 | 有现货 |
|
25MG | ¥737 | 有现货 |
|
50MG | ¥1199 | 有现货 |
|
100MG | ¥1928 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Biotin-PEG2-C2-iodoacetamide
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Biotin-PEG2-C2-iodoacetamide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
产品描述Biotin-PEG2-C2-iodoacetamide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
同义词Biotin-PEG2-C2-iodoacetamide; Biotin-PEG2-iodoacetamide
-
通路Others
-
靶点Other Targets
-
受体SARS-CoV; SARS-CoV 3CLpro
-
研究领域——
-
适应症——
化学信息
-
CAS Number292843-75-5
-
分子量542.4
-
分子式C18H31IN4O5S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES[H][C@]12CS[C@@H](CCCCC(=O)NCCOCCOCCNC(=O)CI)[C@@]1([H])NC(=O)N2
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Ghosh AK, et, al. Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors. Bioorg Med Chem Lett. 2008 Oct 15;18(20):5684-8.
产品手册
关联产品
-
Nelivaptan
Nelivaptan is a non-peptide vasopressin receptor antagonist, it is selective for the V1B subtype.
-
N-Formyl-Nle-Leu-Phe...
N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys TFA (For-Nle-Leu-Phe-Nle-Tyr-Lys-OH TFA) is a formyl peptide receptor (FPR) agonist.Potent chemoattractant for human neutrophils.Radioiodinated molecule has full biological activity.
-
PMEDAP
PMEDAP is a potent inhibitor of Moloney murine sarcoma virus (MSV)-induced tumor formation and associated mortality and an inhibitor of human immunodeficiency virus (HIV) replication. PMEDAP also has anti-murine cytomegalovirus (MCMV) activity.